Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

986 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood test.
Muley T, Zhang X, Holdenrieder S, Korse CM, Zhi XY, Molina R, Liu Z, Hartmann G, van den Heuvel MM, Qian K, Marrades R, Engel C, He Y, Wehnl B, Dayyani F, Herth F. Muley T, et al. Among authors: engel c. Tumour Biol. 2020 Sep;42(9):1010428320958603. doi: 10.1177/1010428320958603. Tumour Biol. 2020. PMID: 32964798 Free article.
Multicenter analytical performance evaluation of a fully automated anti-Müllerian hormone assay and reference interval determination.
Anckaert E, Öktem M, Thies A, Cohen-Bacrie M, Daan NM, Schiettecatte J, Müller C, Topcu D, Gröning A, Ternaux F, Engel C, Engelmann S, Milczynski C. Anckaert E, et al. Among authors: engel c. Clin Biochem. 2016 Feb;49(3):260-7. doi: 10.1016/j.clinbiochem.2015.10.008. Epub 2015 Oct 21. Clin Biochem. 2016. PMID: 26500002 Free article.
Corrigendum to "Multicenter analytical performance evaluation of a fully automated anti-Müllerian hormone assay and reference interval determination" [Clin. Biochem. 49 (2016) 260-267].
Anckaert E, Öktem M, Thies A, Cohen-Bacrie M, Daan NMP, Schiettecatte J, Müller C, Topcu D, Gröning A, Ternaux F, Engel C, Engelmann S, Milczynski C. Anckaert E, et al. Among authors: engel c. Clin Biochem. 2020 Feb;76:47-48. doi: 10.1016/j.clinbiochem.2019.11.007. Epub 2019 Dec 24. Clin Biochem. 2020. PMID: 31879021 No abstract available.
Childhood, adolescent and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers.
Li S, Madanat-Harjuoja L, Leslie G, Barnes DR, Bolla MK, Dennis J, Parsons MT, Apostolou P, Arnold N, Bosse K, On Behalf Of Embrace Collaborators ACA, Cook J, Engel C, Evans DG, Fostira F, Frone MN, Gehrig A, Greene MH, Hackmann K, Hahnen E, Harbeck N, Hauke J, Hentschel J, Horvath J, Izatt L, Kiechle M, Konstantopoulou I, Lalloo F, Yie JNY, Niederacher D, Ritter J, Santamariña M, Schmutzler RK, Searle C, Sutter C, Tischkowitz M, Tripathi V, Vega A, Wallaschek H, Wang-Gohrke S, Wappenschmidt B, Weber BHF, Yannoukakos D, Zhao E, Easton DF, Antoniou AC, Chenevix-Trench G, Rebbeck TR, Diller LR. Li S, et al. Among authors: engel c. J Natl Cancer Inst. 2024 Nov 25:djae306. doi: 10.1093/jnci/djae306. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 39585318
Calculating future 10-year breast cancer risks in risk-adapted surveillance: A method comparison and application in clinical practice.
Zachariae S, Quante AS, Kiechle M, Rhiem K, Fehm TN, Schröder JG, Horvath J, Leinert E, Dikow N, Ronez J, Schönfeld M, van Mackelenbergh MT, Schatz UA, Meisel C, Aktas B, Witt D, Mehraein Y, Weber BHF, Solbach C, Speiser D, Hoyer J, Faigle-Krehl G, Much CD, Mueller-Rausch AV, Villavicencio-Lorini P, Banys-Paluchowski M, Pieh D, Schmutzler RK, Fischer C, Engel C. Zachariae S, et al. Among authors: engel c. Cancer Prev Res (Phila). 2024 Nov 22. doi: 10.1158/1940-6207.CAPR-24-0328. Online ahead of print. Cancer Prev Res (Phila). 2024. PMID: 39575650
Statistical analysis plan for the FiO2-C trial: effects of closed-loop automatic control of the inspiratory fraction of oxygen (FiO2-C) on outcomes of extremely preterm infants-a randomized-controlled parallel group multicentre trial for safety and efficacy.
König J, Stauch A, Engel C, Urschitz MS, Franz AR; FiO2-C study group. König J, et al. Among authors: engel c. Trials. 2024 Nov 12;25(1):756. doi: 10.1186/s13063-024-08615-7. Trials. 2024. PMID: 39533330 Free PMC article.
986 results